Smith & Nephew 

$13.95
604
+$0.85+6.49% 17:10 Today

Statistics

Day High
14.5
Day Low
14.5
52W High
18.5
52W Low
13.1
Volume
1,000
Avg. Volume
1,263
Mkt Cap
5.89B
P/E Ratio
18.19
Dividend Yield
2.7%
Dividend
0.38

Upcoming

Dividends

2.7%Dividend Yield
May 26
$0.24
Nov 25
$0.15
May 25
$0.23
Nov 24
$0.14
May 24
$0.23
10Y Growth
2.39%
5Y Growth
1.45%
3Y Growth
-1.46%
1Y Growth
2.05%

Earnings

4AugExpected
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Next
0
0.2
0.39
0.59
Expected EPS
0.47
Actual EPS
N/A

Financials

10.14%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
6.16BRevenue
625MNet Income

Analyst Ratings

30.00Average Price Target
The highest estimate is 30.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SNNUF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Stryker
SYK
Mkt Cap125.18B
Stryker Corporation is a direct competitor, offering a similar range of orthopedic and medical devices.
Medtronic
MDT
Mkt Cap106.49B
Medtronic plc specializes in medical technologies, services, and solutions, including those for surgical devices, competing in areas overlapping with Smith & Nephew.
Zimmer Biomet
ZBH
Mkt Cap18.01B
Zimmer Biomet Holdings, Inc. competes in the manufacture of musculoskeletal healthcare products, directly overlapping with Smith & Nephew's product lines.
Johnson & Johnson
JNJ
Mkt Cap633.19B
Johnson & Johnson operates in the medical devices sector through its subsidiary DePuy Synthes, which competes in orthopedics, a key area for Smith & Nephew.
Boston Scientific
BSX
Mkt Cap67.09B
Boston Scientific Corporation competes with Smith & Nephew in the medical devices market, particularly in areas of advanced surgical and wound care products.
Intuitive Surgical
ISRG
Mkt Cap150.88B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, competing with Smith & Nephew's advanced surgical technologies.
Abbott Laboratories
ABT
Mkt Cap166.17B
Abbott Laboratories competes in various healthcare segments, including medical devices that overlap with Smith & Nephew's portfolio.
Baxter International
BAX
Mkt Cap11.7B
Baxter International Inc. provides a broad range of hospital and surgical products, competing in the medical supplies and devices sector.
Globus Medical
GMED
Mkt Cap10.88B
Globus Medical, Inc. is a spine and orthopedics-focused company, directly competing with Smith & Nephew in the orthopedic surgery market.
Edwards Lifesciences
EW
Mkt Cap54.34B
Edwards Lifesciences Corporation specializes in heart and critical care products, competing indirectly in the medical devices market.

About

Smith & Nephew plc is a global medical technology enterprise dedicated to the development, manufacturing, and worldwide commercialization of an extensive array of medical devices. Its product portfolio spans several key areas. In orthopedics, the company provides knee implants for replacement procedures, hip implants for joint reconstruction, and trauma and extremities products, including both internal and external fixation devices, crucial for stabilizing severe fractures and correcting deformities. For sports medicine, Smith & Nephew offers joint repair solutions tailored for surgeons. This includes specialized instruments, advanced technologies, and implants essential for minimally invasive joint surgeries, targeting soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. Additionally, the firm supplies arthroscopic enabling technologies that enhance surgical visualization and intervention within joints. This suite encompasses fluid management equipment for surgical access, high-definition cameras, digital imaging capture systems, scopes, light sources, and monitors. It also features radiofrequency, electromechanical, and mechanical tissue resection devices, alongside hand instruments for precise tissue removal. The company also provides dedicated ear, nose, and throat (ENT) solutions. Its Advanced Wound Management division delivers comprehensive solutions for the treatment and prevention of acute and chronic wounds, covering conditions like leg, diabetic, and pressure ulcers, burns, and post-operative wounds. This segment includes advanced wound bioactives, comprising biologics and other bioactive technologies for debridement, dermal repair, and regeneration. Regenerative medicine products, such as skin, bone graft, and articular cartilage substitutes, are also offered. Furthermore, Smith & Nephew provides advanced wound devices, including traditional and single-use negative pressure wound therapy systems, and hydrosurgery technology. Primarily serving healthcare providers globally, Smith & Nephew plc was founded in 1856 and is headquartered in Watford, United Kingdom.
Show more...
CEO
Dr. Deepak S. Nath Ph.D.
Employees
17349
Country
United Kingdom
ISIN
GB0009223206

Listings

0 Comments

Share your thoughts

FAQ

What is Smith & Nephew stock price today?
The current price of SNNUF is $13.95 USD — it has increased by +6.49% in the past 24 hours. Watch Smith & Nephew stock price performance more closely on the chart.
What is Smith & Nephew stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Smith & Nephew stocks are traded under the ticker SNNUF.
Is Smith & Nephew stock price growing?
SNNUF stock has risen by +6.49% compared to the previous week, the month change is a -6.44% fall, over the last year Smith & Nephew has showed a -4.45% decrease.
What is Smith & Nephew market cap?
Today Smith & Nephew has the market capitalization of 5.89B
When is the next Smith & Nephew earnings date?
Smith & Nephew is going to release the next earnings report on August 04, 2026.
What were Smith & Nephew earnings last quarter?
SNNUF earnings for the last quarter are 0.59 USD per share, whereas the estimation was 0.58 USD resulting in a +2.16% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Smith & Nephew revenue for the last year?
Smith & Nephew revenue for the last year amounts to 6.16B USD.
What is Smith & Nephew net income for the last year?
SNNUF net income for the last year is 625M USD.
Does Smith & Nephew pay dividends?
Yes, SNNUF dividends are paid semi-annual. The last dividend per share was 0.24 USD. As of today, Dividend Yield (FWD)% is 2.7%.
How many employees does Smith & Nephew have?
As of July 07, 2026, the company has 17,349 employees.
In which sector is Smith & Nephew located?
Smith & Nephew operates in the Health & Wellness sector.
When did Smith & Nephew complete a stock split?
The last stock split for Smith & Nephew was on October 15, 2014 with a ratio of 2.5:1.
Where is Smith & Nephew headquartered?
Smith & Nephew is headquartered in Watford, United Kingdom.